# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Deal would value the Baxter spinoff at more than $4 billionhttps://www.wsj.com/finance/investing/carlyle-in-advanced-talks-to-a...
Evercore ISI Group analyst Vijay Kumar maintains Baxter Intl (NYSE:BAX) with a Outperform and lowers the price target from $...
Goldman Sachs analyst David Roman initiates coverage on Baxter Intl (NYSE:BAX) with a Neutral rating and announces Price Tar...
Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $44 to $38.